Drugplain

ABACAVIR and LAMIVUDINE 600 mg/1

ABACAVIR and LAMIVUDINE · TABLET, FILM COATED · Camber Pharmaceuticals, Inc.

No Recall History
Plain English

ABACAVIR and LAMIVUDINE is a tablet, film coated containing abacavir and lamivudine at 600 mg/1, taken oral. Manufactured by Camber Pharmaceuticals, Inc..

Key Facts

Brand Name
ABACAVIR and LAMIVUDINE
Generic Name
ABACAVIR and LAMIVUDINE
NDC Code (Product)
31722-838
Manufacturer
Camber Pharmaceuticals, Inc.
Strength
600 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
ANDA205412
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Marketing Start
04/16/2025

Recall History

No Recall History

Frequently Asked Questions

What is ABACAVIR and LAMIVUDINE used for?

ABACAVIR and LAMIVUDINE contains ABACAVIR and LAMIVUDINE. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is ABACAVIR and LAMIVUDINE a controlled substance?

ABACAVIR and LAMIVUDINE is not classified as a controlled substance by the DEA.

What is the generic name for ABACAVIR and LAMIVUDINE?

The generic name for ABACAVIR and LAMIVUDINE is ABACAVIR and LAMIVUDINE. There are 5 other brand versions of ABACAVIR and LAMIVUDINE.

What is the NDC code for ABACAVIR and LAMIVUDINE 600 mg/1?

The NDC (National Drug Code) for ABACAVIR and LAMIVUDINE 600 mg/1 is 31722-838, listed by Camber Pharmaceuticals, Inc..

Product NDC

31722-838

Package NDC

31722-838-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)